Aegerion Pharmaceuticals, Inc. Insider Trading for November 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aegerion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aegerion Pharmaceuticals, Inc. for November 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Plutzky Jorge MD | Director | Option Exercise | D | 25.99 | 31,182 | 810,420 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 2.46 | 69,000 | 169,740 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 5.71 | 200,000 | 1,142,000 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.52 | 40,000 | 780,800 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.58 | 200,000 | 3,916,000 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 0.00 | 8,000 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 2.46 | 17,000 | 41,820 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Louis Roger | Chief Compliance Of ... | Option Exercise | D | 10.42 | 85,000 | 885,700 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 7,300 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 5,100 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 2,500 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 1,733 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 3,500 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 0.00 | 3,282 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.19 | 30,000 | 395,700 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 26.00 | 3,399 | 88,374 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 26.00 | 1,701 | 44,226 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 47.11 | 14,324 | 674,804 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 47.11 | 2,676 | 126,066 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 39.02 | 10,683 | 416,851 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 39.02 | 1,817 | 70,899 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.39 | 15,096 | 202,135 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Option Exercise | D | 13.39 | 25,529 | 341,833 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Harshbarger Benjamin | General Counsel and ... | Sell | D | 0.00 | 1,704 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Chan Barbara Y | VP, Chief Accountin ... | Option Exercise | D | 1.58 | 26,000 | 41,080 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 0.00 | 4,000 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 2.46 | 7,000 | 17,220 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Buono Linda | Sr. VP, Human Resou ... | Option Exercise | D | 5.43 | 75,000 | 407,250 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Option Exercise | D | 37.66 | 14,700 | 553,602 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | VANLENT ANNE | Director | Sell | D | 0.00 | 4,000 | 0 | 0 | 4 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Option Exercise | D | 15.26 | 23,521 | 358,930 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | THOMAS PAUL | Director | Sell | D | 0.00 | 36,978 | 0 | 0 | 37 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 0.00 | 97,000 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 2.46 | 194,000 | 477,240 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Szela Mary T | Chief Executive Off ... | Option Exercise | D | 8.65 | 600,000 | 5,190,000 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Stern Donald K | Director | Option Exercise | D | 17.68 | 31,182 | 551,298 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 0.00 | 8,888 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 18.26 | 40,000 | 730,400 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 15.00 | 8,569 | 128,535 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.28 | 16,435 | 267,562 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Sell | D | 0.00 | 2,890 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | D | 9.50 | 10,238 | 97,261 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | GOTTO ANTONIO M JR MD D PHIL | Director | Sell | D | 0.00 | 13,916 | 0 | 0 | 13.9 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | D | 0.00 | 521,350 | 0 | 0 | 521.4 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | Scheer David | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 15.00 | 12,854 | 192,810 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 17.64 | 9,988 | 176,188 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Option Exercise | D | 19.25 | 19,927 | 383,595 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | BARER SOL J | Director | Sell | D | 0.00 | 29,890 | 0 | 0 | 29.9 K to 0 (-100.00 %) |